Not exact matches
Young explained that using proteins rather than live agents to
produce an immune
reaction significantly reduces the chance of
side effects.
The team found that with the right combination of metals, voltage, and temperature, STEP's coulombic efficiency (a classic measure of chemical yield used to determine how efficiently the product is made) hovered around 95 %, meaning that in STEP's case, 95 % of the current worked toward
producing the carbon nanofibers, and only 5 % powered other
side reactions.
Protein - replacement therapy using mRNA offers a theoretically attractive alternative because mRNA is relatively easy and inexpensive to
produce, and seems less likely to cause
side effects or induce a problematic immune
reaction because the proteins are made in a person's own body, and undergo the desired modifications, according to Verma.
Usually these lesions will
produce postural
reaction deficits or additional cranial nerve abnormalities on the affected
side, which aid in determining on which
side a lesion is located.